{"nctId":"NCT01883817","briefTitle":"Effect of Omega-3 Fatty Acid on Cortical Function in ADHD","startDateStruct":{"date":"2013-09"},"conditions":["Attention Deficit Disorder"],"count":30,"armGroups":[{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"DHA Omega-3","type":"EXPERIMENTAL","interventionNames":["Drug: DHA Omega-3"]}],"interventions":[{"name":"DHA Omega-3","otherNames":["Docosahexaenoic acid","Omega 3 Fatty Acids"]},{"name":"Placebo","otherNames":["Inactive drug"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Provision of written informed consent/assent\n* Ages 5-15 years old\n* Meets DSM-IV-TR criteria for ADHD as determined by the KSADS\n\nExclusion Criteria:\n\n* Contraindication to an MRI scan (i.e., braces, claustrophobia)\n* A history of a major medical (e.g., diabetes) or neurological illness (e.g., epilepsy)\n* Greater than 1 year outside appropriate age/grade level\n* A history of intolerance or hypersensitivity to omega-3 fatty acids\n* Currently taking omega-3 supplements\n* Not proficient in English language\n* Any history of a hematological disorder or concomitant use of anticoagulant medications\n* Personal history of an Axis I psychiatric disorder other than ADHD\n* Inability to swallow capsules","healthyVolunteers":false,"sex":"ALL","minimumAge":"5 Years","maximumAge":"15 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Attention-Deficit Hyperactivity Disorder Symptom Ratings Using the ADHD Rating Scale (ADHD-RS-IV)","description":"Attention-Deficit Hyperactivity Disorder Rating Scale Version IV (ADHD-RS-IV) Min score: 0 Max score: 54 Higher score = more severe ADHD symptoms","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"47.1","spread":"8.5"},{"groupId":"OG001","value":"46.1","spread":"6.6"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":14},"commonTop":[]}}}